<DOC>
	<DOCNO>NCT01632397</DOCNO>
	<brief_summary>Following formative work , propose study open-label , pilot , randomize , two arm trial subject receive pre-exposure prophylaxis ( PrEP ) 6 month either cognitive-behavioral base adherence intervention health education supportive counseling .</brief_summary>
	<brief_title>Pre-exposure Prophylaxis Adherence Intervention MSM</brief_title>
	<detailed_description />
	<criteria>male sex birth 18 year old old test HIVnegative screen evidence high risk HIV acquisition define unprotected anal sex ( insertive receptive ) HIVpositive male partner OR least total three episode unprotected anal sex least two partner last three month medically clear take study drug ( ambulatory performance &gt; =60 Karnofsky scale , adequate renal function , negative glucose protein urine , adequate hepatic function , adequate hematologic function ) able understand speak English ( consent counsel ) . participant able consent due psychiatric cognitive concern already prescribe PrEP history current medical condition would preclude take study drug ( e.g. , previously diagnose active serious infection , acute chronic hepatitis B , history pathological bone fracture relate trauma ) receive ongoing therapy ART , agent significant nephrotoxic potential , agent may inhibit compete elimination via active renal tubular secretion , investigational agent receive possibly receive antiretroviral drug antiHIV vaccine clinical trial active alcohol drug use would interfere study participation condition ( base opinion investigator designee ) would preclude informed consent , make study unsafe , complicate interpretation study outcome data , otherwise interfere study procedure</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>PrEP</keyword>
	<keyword>HIV</keyword>
	<keyword>Adherence</keyword>
	<keyword>MSM</keyword>
	<keyword>Men sex men</keyword>
</DOC>